𝔖 Bobbio Scriptorium
✦   LIBER   ✦

44 – Clinical and functioning outcomes of risperidone long-acting injection versus oral antipsychotics in schizophrenia

✍ Scribed by J.M. Olivares; A. Rodriguez-Morales; J. Diels; M. Povey; A. Lam; A. Jacobs; Z. Zhao

Book ID
119363470
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
73 KB
Volume
98
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switching stable patients with schizophr
Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome
✍ Keith Lloyd; Muhammud A. Latif; Steve Simpson; Keshar L. Shrestha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective This international, non‐randomised study evaluated maintained efficacy and safety of Risperidone Long‐Acting Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e

Effects of switching to long-acting inje
Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia
✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral